Subprojects KFO 179: 2011-2014
SP 1:
SP 2: Novel therapeutic targets
SP 4: Immuno-PET for prediction of tumor response
SP 5: Predictive and prognostic biomarkers in locally advanced rectal cancer
SP 6: Toxcity, Pharmacogenomic
SP 7: Tyrosine kinase receptors and molecular resistance mechanisms
SP 8: Biostatistics and IT
SP 9: Individualized Medicine
SP 10: AURORA-A Oncogene
SP C: Administration
